Design Therapeutics

Design Therapeutics is a biopharmaceutical company focused on developing novel, small-molecule therapeutic candidates. Their mission is to provide functional cures for serious genetic diseases with unmet needs. Their proprietary GeneTAC™ platform leverages a deep understanding of gene regulation and the power of small molecules to target the underlying cause of genetic disorders. This approach involves designing small molecules that can either "dial up" or "dial down" the expression of specific genes, ultimately addressing the root cause of the disease.

Design Therapeutics has a robust pipeline of candidates, with an initial focus on monogenic repeat expansion disorders such as Friedreich ataxia, Fuchs endothelial corneal dystrophy, Huntington's disease, and myotonic dystrophy. Their commitment to scientific advancement and patient well-being is evident in their efforts to develop treatments that have the potential to improve the lives of individuals suffering from these debilitating diseases.

Design Therapeutics offers a comprehensive benefits package to employees, including health coverage with medical, dental and vision plans and FSA options, employer funded benefits such as life, AD&D, short- and long-term disability insurance, and an Employee Assistance Program. They also provide generous time off with three weeks paid time off and 12 paid holidays, as well as an employer-matching 401k contribution. Additional employee perks and programs include an employer stock purchase plan (ESPP), cell phone and home internet reimbursement, employer-paid medical concierge membership with One Medical, office lunches and snacks, and company-sponsored happy hours and social events.

Design Therapeutics is a biopharmaceutical company focused on developing innovative, small-molecule therapeutic candidates that address the root cause of serious genetic diseases with significant unmet needs. Their GeneTAC™ platform leverages their expertise in gene regulation and small molecules to create disease-modifying treatments for inherited nucleotide repeat expansion disorders, such as Friedreich ataxia, Fuchs endothelial corneal dystrophy, Huntington’s disease, and myotonic dystrophy.

Design Therapeutics fosters a culture that values curiosity, creativity, and collaboration, promoting an environment where employees can meaningfully impact the health of countless people suffering from debilitating diseases. They prioritize out-of-the-box thinking, a compassionate mindset, and a driven attitude while supporting opportunities for professional growth and development.